8357.HK HKSE
Republic Healthcare Limited
1W: +87.1%
1M: +57.4%
3M: +18.7%
YTD: -16.3%
1Y: +6.0%
3Y: -12.6%
5Y: +1.3%
HK$0.16 ($0.02)
+0.00 (+0.63%)
Weekly Expected Move ±31.4%
HK$0
HK$0
HK$0
HK$0
HK$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$8M
-15.0% ▼
5Y CAGR: -10.8%
Gross Profit
-$24K
-100.4% ▼
Operating Income
-$3M
-257.8% ▼
Net Income
-$3M
-1563.7% ▼
EPS (Diluted)
$-0.00
-1500.0% ▼
EBITDA
-$2M
-833.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $14M | $9M | $10M | $9M | $8M |
| YoY Growth | +0.6% | -32.4% | +8.9% | -10.2% | -15.0% |
| Cost of Revenue | $4M | $3M | $3M | $3M | $8M |
| Gross Profit | $9M | $6M | $3M | $6M | -$24K |
| Gross Margin | 65.3% | 63.2% | 26.2% | 70.2% | -0.3% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2M | $626K | $819K | $557K | $3M |
| Operating Expenses | $2M | $7M | $8M | $557K | $3M |
| Operating Income | -$1M | $1M | $2M | $2M | -$3M |
| Operating Margin | -9.8% | 13.4% | 18.3% | 18.4% | -34.2% |
| Interest Expense | $118K | $57K | $54K | $47K | $260K |
| Income Before Tax | -$1M | -$1M | -$828K | -$184K | -$3M |
| Tax Expense | -$20K | $28K | $27K | -$5K | -$25K |
| Net Income | -$998K | -$1M | -$855K | -$178K | -$3M |
| Net Margin | -7.1% | -15.7% | -8.3% | -1.9% | -37.8% |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | $963K | -$388K | $29K | -$189K | -$2M |
| Shares Outstanding | 551M | 624M | 624M | 624M | 624M |